International Prognostic Index (IPI) and Revised IPI (R-IPI)
Estimates prognosis in aggressive non-Hodgkin lymphoma / DLBCL from five adverse factors, producing both the classic IPI and the contemporary R-IPI risk groups; use only with confirmed aggressive NHL / DLBCL histology.